Diabetes Drug Slows Experimental Parkinson's Progression, Human Trials to Begin Next Year (VIDEO)

Van Andel Research Institute

Caption

Dr. Patrik Brundin discusses MSDC-0160 and its importance for human clinical trials in search of the world's first treatment to impede the progression of Parkinson's disease.

Credit

Video courtesy of the Patrik Brundin Laboratory, Van Andel Research Institute.

Usage Restrictions

Credit the video: 'Video courtesy of the Patrik Brundin Laboratory, Van Andel Research Institute."

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.